InstantGMP™ Transforms Manufacturing with Equipment Integration

Cary, NC – InstantGMP Inc., creator of an Electronic Batch Record system, InstantGMP™ MES 3.0, announces the release of a new feature that connects equipment on the production floor with its cloud-based software. The feature is aimed at helping companies that use InstantGMP™ MES to take their compliance and quality to new levels by accurately[…]

Are Art and Design the Future of Biotech?

When you think about biotech and medical devices, do you connect their design with art and design students? Traditionally, tech and devices have been born from the minds of engineers and scientists, but the Biodesign Summit in New York City hosted these students to show off their conceptual designs. Students from Rensselaer Polytechnic Institute designed[…]

FDA Approves Abbott Absorb First-of-a-Kind Dissolvable Heart Stent

The Food and Drug Administration (FDA) has approved the Abbott Absorb, the first fully-dissolving heart stent in the US. Abbott’s Absorb GT1 is approved and available in over 100 countries outside the US and now has the go-ahead from the FDA. The GT1 Bioresorbable Vascular Scaffold (BVS) System is made from pol(L-lactide), which is a[…]

Turbulence Ahead for Europe’s Pharma Industry Following Brexit

As the votes were being tallied, the entire world had its eye on the UK. The implications of “Brexit” reverberated around the world as it waited with baited breath. In a 52-48 majority, the UK decided to exit the European Union (EU) after close to 50 years. The actual implementation of Brexit will not be[…]

UK Pharmaceutical Sector Bracing for Regulatory Shake-Up Following Brexit Possibility

From Elza Homstedt Pell of EurActiv, pharmaceutical companies are closely watching the “Brexit” referendum for the UK to leave or stay in the European Union (EU) and how it could shake up the pharma regulators. Pell argues that the UK would lose its regulatory influence in pharma over the European Medicines Agency (EMA) if the[…]